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The brain is responsible for maintaining whole-body energy homeostasis by changing
energy input and availability. The hypothalamus and dorsal vagal complex (DVC) are the
primary sites of metabolic control, able to sense both hormones and nutrients and adapt
metabolism accordingly. The mitochondria respond to the level of nutrient availability by
fusion or fission to maintain energy homeostasis; however, these processes can be
disrupted by metabolic diseases including obesity and type II diabetes (T2D).
Mitochondrial dynamics are crucial in the development and maintenance of obesity and
T2D, playing a role in the control of glucose homeostasis and whole-body metabolism
across neurons and glia in the hypothalamus and DVC.
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Mitochondria are essential for the control of energy metabolism and their dysfunction plays a key
role in the pathophysiology of obesity and type II diabetes (T2D). They are dynamic organelles that
change morphology in response to energy demand and supply via fission and fusion. Fission is
mediated by the GTPase dynamin-related protein 1 (DRP1) and occurs when mitochondria are
damaged or subjected to high levels of cellular stress (1, 2). DRP1 is recruited to the outer
mitochondrial membrane (OMM) where it oligomerizes to form a ring structure to constrict the
mitochondrion and fragment it (3, 4); this allows for a reduction in ATP content when energy
supply exceeds demand. Fusion is also mediated by GTPases which include mitofusin 1 (MFN1),
mitofusin 2 (MFN2), and optic atrophy protein 1 (OPA1) (5–7). MFN1 and MFN2 are anchored to
the OMM and mediate fusion there, while OPA1 is involved in inner mitochondrial membrane
(IMM) fusion. Mitochondrial fusion serves to repair damaged mitochondria by fusing them with a
functional one and also increases ATP production to meet metabolic demand (2). Mice lacking
Drp1, Mfn1, Mfn2, or Opa1 are embryonic lethal (5, 8–10), demonstrating their essential role in
development and highlighting their potential to influence metabolism if expression levels change.
Circuits within the central nervous system (CNS) control whole-body energy metabolism. The
hypothalamus and the dorsal vagal complex (DVC) have been highlighted as crucial regulatory
centers of metabolism, and dysfunction of mitochondria in these regions has been implicated in
metabolic disorders. The arcuate nucleus (ARC) of the hypothalamus and area postrema (AP) of the
DVC are sites with increased blood–brain barrier (BBB) permeability allowing for detection ofn.org November 2020 | Volume 11 | Article 5808791
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hormones that have restricted entry to other brain regions (11). The
ability to sense humoral signals means these regions can respond to
environmental cues and adapt metabolism accordingly. Within the
ARC, anorexigenic proopiomelanocortin (POMC)- and orexigenic
agouti-related peptide (AgRP)-expressing neurons regulate energy
expenditure, glucose homeostasis, and food intake in an
antagonistic fashion. Glial cells are also involved in body weight
homeostasis, glucose metabolism, and obesity, with roles for both
microglia and astrocytes (12–16).
In this review, we discuss the contribution of mitochondrial
dynamics and dysfunction in the brain to the central control of
metabolism and glucose homeostasis and their role in the
metabolic disorders obesity and T2D.BRAIN INFLAMMATION, ER STRESS AND
MITOCHONDRIA IN OBESITY AND T2D
The body must respond and adapt to changing levels of energy
input and availability by altering metabolism. This occurs at the
molecular and transcriptional levels to give systems level changes
and alterations in behavior. Mitochondria respond to nutrient
availability by fusion or fission to maintain homeostasis;
however, these processes can be disrupted by metabolic
disease. Obesity and its many co-morbidities are associated
with chronic inflammation, ER stress, and disrupted
mitochondrial dynamics in several tissues [reviewed in (17–20)].
Obesity triggers a chronic low-grade inflammatory response
in multiple organs which presents a complex challenge for
deciphering the disease mechanisms. The mitochondria
produce adenosine triphosphate (ATP) using nutrients and
oxygen in a series of stepwise reactions that occur at the inner
mitochondrial membrane (IMM). This process is the main
source of reactive oxygen species (ROS), important for cell
functions and acting as a signaling molecule; however, high
ROS levels are associated with cell damage. Excessive nutrient
intake overloads the mitochondria with glucose and fatty acids
leading to an increase in ROS production and associated
oxidative stress in the skeletal muscle (21, 22). Obesity leads to
reduced b-oxidation, a process where fatty acids are broken
down to generate acetyl-CoA for use in the citric acid cycle (23).
The reduction in b-oxidation impairs cellular functions via
increased triacylglycerol synthesis and ectopic deposition of
lipids; it also causes oxidative stress via an increase in lipid
peroxidation byproducts, increased nitric oxide synthase, and
excess ROS (24). High-fat diet (HFD) in rats reduced the activity
of antioxidant enzymes superoxide dismutase, glutathione
peroxidase, and catalase in the brain, thus further increasing
ROS levels (25). When ROS production is exacerbated, for
example by increased lipid availability, mitochondrial
dysfunction is induced, and ATP production is decreased (26).
ROS activate several transcription factors including NF-kB,
which is the primary mediator of the inflammatory response.
HFD in mice increased NF-kB activity in multiple tissues (27)
and activated inflammatory pathways in the hypothalamusFrontiers in Endocrinology | www.frontiersin.org 2leading to insulin resistance (28, 29). Levels of macrophages
and T cells are increased in the skeletal muscle of obese patients
with insulin resistance or T2D (30, 31), and short-term
overfeeding in healthy subjects increased macrophage markers
in the skeletal muscle and impaired insulin signaling (32),
illustrating that inflammatory processes are also triggered by
metabolic disorder in humans. Another family of inflammatory
molecules c-Jun N-terminal kinases (JNKs) are activated in
obesity; when JNK1 KO mice were fed HFD they gained less
weight, had smaller adipocytes, and improved insulin sensitivity
compared to wildtypes (33). Immune responses throughout the
body and metabolic regulation are highly integrated, and the
proper function of each is dependent on the other.
The endoplasmic reticulum (ER), a complex protein folding
and trafficking organelle, interacts with the mitochondria and is
another source of ROS. The ER can transduce signals from lipid
metabolites and cytokines to stress kinases and plays an
important role in insulin resistance (34). ER-mediated ROS
production is increased in insulin resistant non-diabetic obese
patients and T2D patients (35, 36). During cellular stress, as seen
in T2D patients, ER function is disrupted by the unfolded protein
response (UPR); this leads to calcium leakage from the ER which
interferes with electron transfer in the electron transport chain
and ultimately induces mitochondrial ROS production (37).
There are three major transducers of the UPR: protein kinase
RNA (PKR)-like ER kinase (PERK), inositol-requiring enzyme 1
(IRE1), and activating transcription factor 6 (ATF6).
Downstream signaling leads to transcription of UPR target
genes including upregulation of molecular chaperones and
folding catalysts to increase the folding capacity of the ER,
conveying a protective effect for cell survival. The UPR is an
acute response to re-establish cellular homeostasis following
stress; however, if sustained chronically it can lead to disease
including obesity, T2D, and neurodegenerative disorders to
name a few (38). ER stress is triggered in obese subjects by the
release non-esterified fatty acids from visceral adipose tissue
which causes the increased expression of cytokines and
activation of PERK (39). Phosphorylated PERK modulates
insulin responsiveness in adipose tissue through generation of
phosphatidic acid, an inhibitor of insulin action (40).
Furthermore, PERK-dependent mechanisms can induce
positive ER stress feedback that perpetuates the process,
contributing to the development of insulin resistance (39). A
recent in vitro study found that ER stress and the UPR cause
insulin resistance by depleting the cell surface population of the
insulin receptor, impairing the transport of newly synthesized
proreceptors (41). This effect of ER stress on trafficking insulin
receptors to the surface may account for the decrease in insulin
receptors seen in T2D patients. ER stress was detected in the
hypothalamus of leptin-deficient neonate mice (ob/ob) before the
development of obesity at postnatal day 10 (P10) (42).
Administration of the ER stress-relieving compound TUDCA
during a critical developmental window for the hypothalamus
(P4–P16) provided beneficial effects on body weight, food intake,
adiposity, and glucose homeostasis that persisted into adulthood
(42). ER stress throughout life therefore has a strong impact onNovember 2020 | Volume 11 | Article 580879
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involved in feeding behavior.
Along with an upregulation in mitochondrial ROS
production, dysfunction in mitochondrial dynamics is also
associated with metabolic disease. A decrease in number of
mitochondria and reduction in bioenergetic capacity have been
measured in T2D patients (43). Reduced expression of the
mitochondrial fusion mediator MFN2 was seen in skeletal
muscle of obese Zucker rats and non-obese T2D patients (44,
45). Both genetically obese and diet-induced obese mice were
found to have smaller and shorter mitochondria in the skeletal
muscle, while inhibition of fission improved systemic insulin
sensitivity (46). Rats on HFD for 8 weeks presented with
impaired mitochondrial respiration and insulin resistance in
hepatocytes (47). Treatment of hepatocytes with high glucose
caused the mitochondria to become smaller and shorter; when a
dominant negative form of DRP1, Drp1-K38A (a point mutation
at Lysine-38 to Alanine in the catalytic site) was expressed in the
cells, mitochondrial fission was prevented following glucose
administration (48). In the adipose tissue of morbidly obese
patients, an inverse relationship was found between the
regulation of inflammation and mitochondrial function (49),
and adipocytes in obese and diabetic mouse models had
decreased mitochondrial mass and function (50).
Clear roles for aberrant mitochondrial dynamics have
therefore been shown in peripheral tissues during the
development of insulin resistance and obesity. Oxidative stress
and ER stress are associated processes that both result in
inflammation and are linked to the development of insulin
resistance in many tissues including liver, skeletal muscle,
adipose tissue, and brain. Mitochondria are crucial in
maintaining energy balance and are therefore key players in
the pathophysiology of metabolic disorders in peripheral organs
as well as in the central nervous system.ENERGY HOMEOSTASIS AND
MITOCHONDRIAL DYNAMICS IN
THE HYPOTHALAMUS
The mediobasal hypothalamus (MBH) is critical for the
regulation of appetite, feeding behavior, and body weight.
Specific populations of neurons within the ARC respond to
circulating hormones including insulin, leptin, and ghrelin to
maintain energy homeostasis (51). AgRP/NPY neurons release
GABA and directly inhibit POMC neurons (52). The binding of
insulin in the ARC causes hyperpolarization of AgRP neurons
via PI3K/Akt pathway and subsequent ATP-sensitive K+ (KATP)
channel activation, alleviating the inhibitory constraints on
POMC neurons (53, 54). Insulin binding in the ARC causes a
decrease in hepatic glucose production (HGP) via vagal efferent
signaling to the liver (55) and promotes negative energy balance
by reducing food intake (56). Leptin binding in the ARC activates
POMC neurons and inhibits AgRP neurons to reduce feeding,
increase energy expenditure, and decrease HGP (57–59). The
central action of these hormones plays an important role in theFrontiers in Endocrinology | www.frontiersin.org 3control of whole-body metabolism through signaling to
peripheral organs. Insulin and leptin resistance are hallmarks
of obesity, occurring following overnutrition and before the
onset of major weight gain (60), and both are associated with
mitochondrial dysfunction in the brain (61).
In hunger-promoting AgRP/NPY neurons, fasting increases
mitochondrial fission whereas feeding and overnutrition
promote fusion via MFN1 and MFN2 (62) (Figure 1). In a
mouse model of diet-induced obesity (DIO), silent AgRP/NPY
neurons presented with mitochondria that were increased in size
and more elongated than those in wildtypes (62), demonstrating
a role for mitochondrial fusion in AgRP neuronal response to
overnutrition. Interfering with mitochondrial fusion in AgRP
neurons by deletion of Mfn1 or Mfn2 resulted in altered
mitochondria size and density, as well as some physiological
phenotypes (62). Mice lacking Mfn1 in AgRP neurons displayed
no metabolic phenotypes on a regular chow diet; however,
following HFD food intake and body weight were decreased in
female mice, and AgRP neuronal firing rate was decreased in
both males and females.Mfn2 deletion in AgRP neurons did not
alter the number of mitochondria but led to a decrease in body
weight of females fed regular chow. AgRP-Mfn2−/−mice fed HFD
gained less weight compared to wildtype mice. AgRP firing rate
was decreased, and the number of mitochondria was increased
due to failed fusion (62). Altogether these data indicate a critical
role for mitochondrial fusion in AgRP neurons in the
maintenance of metabolism and appropriate weight gain
following overnutrition.
Mitochondrial remodeling enzymes are also implicated in
anorexigenic POMC neuronal signaling. Following feeding,
mitochondrial fusion occurs in POMC neurons; this is
mediated by a reduction in activated DRP1 levels (63) (Figure
1). Deletion of Mfn1 and Mfn2 in POMC neurons leads to a
strikingly different phenotype compared to AgRP/NPY-specific
deletion of these key fusion proteins (62, 64, 65). MFN1 and
MFN2 have non-redundant and distinct roles; MFN1 is more
efficient at mediating the process of mitochondrial fission than
MFN2 (66), whereas MFN2 is also involved in the establishment
of mitochondrial-endoplasmic reticulum (ER) contacts (67).
These differences are exemplified by discordant alterations in
POMC neuron function following specific KO of either Mfn1
(65) or Mfn2 (64).
In DIO mice downregulation of Mfn2 alters mitochondrial
network dynamics, reduces mitochondria–ER contacts, and
impairs intracellular Ca2+-handling (64, 68). Ablation of Mfn1 in
POMC neurons in mice led to defective mitochondrial architecture
remodeling following feeding (65). Mice also presented with
reduced insulin secretion by pancreatic b-cells after glucose
challenge; this was recovered following administration of a
sympathetic antagonist, suggesting a neural basis for the
mechanism. Loss of Mfn1 caused an increase in mitochondrial
respiration and ROS production in fed, but not fasting, conditions
compared to wildtype mice (65). Deletion of Opa1 in the same
neuronal population caused reduced mitochondrial fusion;
however, neuronal activation, insulin secretin and hypothalamic
ROS production remained unchanged (65). Selective ablation ofNovember 2020 | Volume 11 | Article 580879
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resistance, hyperphagia, and a reduction in energy expenditure and
obesity (64). MFN2 is involved in tethering the ER to mitochondria
(67), and deletion is known to cause ER stress (64, 69).
Mitochondria–ER contacts were significantly reduced in
POMCMfn2KO mice; ER stress markers were upregulated, and
ROS levels were increased (64). Interestingly, antioxidant enzymes
were increased in the hypothalamus of these mice, suggesting a
potential compensatory mechanism to reduce excess ROS. When
ER stress was relieved with the chemical chaperone 4-phenylbutyric
acid (4-PBA) food intake and body weight were normalized in
POMCMfn2KO mice, while there were no changes in control mice
(64). Together these data highlight the role of mitochondrial fusion
and ER stress in POMC neurons as regulators of central metabolic
signaling and responsiveness to circulating satiety factors both
centrally and in peripheral tissues. In further agreement for the
role of mitochondrial fusion in POMC neuron function, the fission
mediator DRP1 was found to be phosphorylated (Ser616) and active
in silent POMC neurons (63). Inducible deletion of Drp1 in POMC
neurons led to increased neuronal activity, improved leptin
sensitivity, and glucose metabolism, as well as increased hepatic
glucose output (63). Mitochondria were increased in size, and ROS
production was increased.
Anorexigenic POMC neurons are inhibited by increased
mitochondrial fission leading to reduced energy expenditure
and increased weight gain. Conversely, when fission is
increased in orexigenic AgRP/NPY neurons it is beneficial in
terms of weight gain, and increased caloric intake does not result
in the same increase in body weight. HFD is associated with
mitochondrial fusion in both POMC and AgRP neurons with
opposing effects on neuronal activity; POMC neuronal activity
decreases, while AgRP neuronal activity increases, leading to
further increased food intake (62, 68) (Figure 1). Collectively,
these data demonstrate the importance of mitochondrialFrontiers in Endocrinology | www.frontiersin.org 4dynamics in neuronal populations of the MBH and their role
as essential regulators in the modulation of metabolism.MITOCHONDRIAL DYNAMICS AND
WHOLE-BODY METABOLISM IN THE DVC
More recently it was discovered that the DVC of the brainstem is
involved in metabolic homeostasis and central response to
insulin (70–72). The DVC consists of three regions: the dorsal
motor nucleus (DMX), the nucleus tractus solitarius (NTS), and
the AP. It is a site of integration, receiving signals from the
peripheral organs and relaying them to the brain, while also
relaying brain signals to the peripheral organs; this makes it a
crucial region when studying neuronal control of physiological
functions. Insulin in the DVC activates Erk1/2 rather than PI3K/
Akt signaling as it does in the MBH (70). Infusion of insulin in
the DVC of rodents lowered hepatic glucose production, and
activation of KATP channels was required for insulin-Erk1/2
action (70).
HFD feeding in rodents induces insulin resistance (60), both
in peripheral organs and in the brain (70, 73). After just three
days of HFD infusion of insulin into the DVC fails to activate
Erk1/2, where this central insulin resistance occurs prior to
substantial weight gain and is bypassed by activation of KATP
channels in the DVC by diazoxide (70). Furthermore, acute
insulin infusion into the DVC decreased food intake in regular
chow fed rats but failed to do so in HFD-fed rats (71). Upon
overnutrition, mitochondria undergo Drp1-mediated fission in
DVC neurons, thereby suggesting a role for mitochondrial
dynamics in DVC insulin resistance (72) (Figure 1). Indeed,
inhibition of DRP1 via infusion of MDIVI-1, which blocks DRP1
translocation from the cytosol to the mitochondria (74), in theFIGURE 1 | Changes to mitochondrial dynamics in response to diet in the hypothalamus and DVC: Mitochondrial dynamics in the brain change depending on
energy status. In the hypothalamus, neurons favor mitochondrial fusion following feeding and fission when fasted. The activity of AgRP and POMC neurons are
antagonistic; following feeding AgRP neurons decrease activity while POMC neuron activity is increased while in the fasted state it is the opposite. Following high-fat
diet (HFD) mitochondria favor fusion and become enlarged; AgRP neurons are highly active, and POMC neuronal activity is decreased. In microglia of the
hypothalamus mitochondria favor fission with HFD, and there is an increase in the number of activated microglia in the ARC. There is also an increase in the number
of astrocytes in the hypothalamus with HFD, and knockout of the insulin receptor (IR-KO) in astrocytes led to favoring mitochondrial fission. In the DVC, HFD leads to
mitochondrial fission when compared to regular chow (RC) fed rodents.November 2020 | Volume 11 | Article 580879
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dynamics and prevented the development of insulin resistance
(72). DRP1 is regulated by post-transcriptional modifications
including phosphorylation and SUMOylation (75); a decrease in
phosphorylation of serine-637 increases DRP1 activity (76).
When Drp1 activity was increased via delivery of a phospho-
deficient mutant (Drp1-S637A) in the DVC of healthy regular
chow fed rats, insulin resistance was induced (72). ER stress is
necessary for Drp1-dependent mitochondrial fission to induce
insulin resistance in the DVC. When the ER stress inhibitor 4-
PBA was delivered to the DVC of HFD-fed rats, the ability of
insulin to lower glucose production was restored (72). Together
these data demonstrate the importance of Drp1-mediated
mitochondrial fission and ER stress in the DVC in the
development of insulin resistance following overnutrition and
highlight the potential therapeutic targets in the treatment of
obesity and T2D.
Studies into the role of mitochondrial dysfunction in the
brainstem and the effect on metabolism are still relatively novel. It
is yet to be elucidated whether disruption of mitofusins or OPA1 in
the DVC can alter feeding behavior and HGP. While there is a clear
role for mitochondrial dysfunction in the development of insulin
resistance in the DVC, it is unknown as to whether it also
contributes to leptin resistance. More research is therefore
required to define the role of mitochondria in the DVC in the
development of obesity and T2D.ENERGY HOMEOSTASIS AND
MITOCHONDRIAL DYNAMICS IN
GLIAL CELLS
Mitochondrial function is crucial to all cell types, and disruption
in glial cells of the brain is associated with metabolic disorders
(14). Astrocytes and microglia produce cytokines that drive
inflammation and thus are mediators of the response to
overnutrition and are involved in the development of obesity
and T2D (77). Astrocytes and microglia may develop a reactive
phenotype in response to injury or disease, also referred to as
gliosis, which can be measured by changes in morphology and
protein expression. Acute gliosis is protective and beneficial to
neurons, but chronic activation can be detrimental. Increased
gliosis has been measured in the hypothalamus of obese humans
and in rodent models of obesity (77) (Figure 1).
Astrocytes regulate essential aspects of CNS function and
brain energy metabolism (78). Their physical proximity to blood
vessels and ability to transport nutrients mean they are directly
affected by nutrient excess. Astrocytes exhibit a high rate of
oxidative metabolism (79) and can switch between oxidative
phosphorylation and glycolysis for their energy supply
depending on local energy needs (80, 81). Inflammation alters
mitochondrial dynamics in astrocytes where Drp1 is
phosphorylated leading to increased fission, ROS production,
and reduced respiratory capacity (82). Thus, the low-grade
chronic inflammation associated with obesity is likely to
mediate some of its effect via astrocytes.Frontiers in Endocrinology | www.frontiersin.org 5Mice fed HFD for 10 days had an increased number of
astrocytes in the ARC of the hypothalamus (83) (Figure 1).
Inhibition of NF-kB in astrocytes prevented acute HFD-induced
astrocyte activation and reduced food intake (84). DREADD-
mediated activation of astrocytes in the DVC of mice reduced
dark-phase feeding and reduced refeeding after overnight fasting
(12). Furthermore, activation of DVC astrocytes induced
signaling in the lateral parabrachial nucleus (12), another
region involved in appetite regulation and glucose homeostasis
(85–87). Conditional deletion of Mfn2 in astrocytes of mice led
to a reduction in mitochondria–ER contact sites within
astrocytes and associated disruption of calcium buffering;
however, this study did not measure changes related to feeding
(88). Targeted postnatal ablation of the insulin receptor in
astrocytes of mouse hypothalamus did not alter body weight
compared to control mice in either regular chow or high-fat,
high-sugar diet, but mitochondria within astrocytes were fewer
and smaller in response to elevated blood glucose levels (16)
(Figure 1). HFD promoted loss of synapses on POMC neurons
in the ARC due to reactive gliosis where glial ensheathment of
the soma was increased (89). This altered synaptic organization
led to increased POMC tone and a decrease in excitatory
connections onto neighboring neuropeptide Y (NPY) cells.
These data highlight the role of astrocyte–neuronal crosstalk
in energy homeostasis and how altered astrocyte function can
affect mitochondrial networks in neurons. As yet, more work is
needed to elucidate the role of mitochondrial dynamics and
dysfunction in astrocytes and how these relate to whole body
metabolism, feeding behavior, and hormone sensitivity in the
hypothalamus and DVC.
Microglia are the immune cells of the central nervous system,
acting to protect from invaders and orchestrating the
inflammatory response. Three days of HFD in rats led to an
increased number of microglia in the ARC compared to regular
chow fed controls along with increased expression of
inflammatory mediators including IL-6 and SOCS3 (77)
(Figure 1). Central modulation of inflammation by inhibition
of sodium-glucose transporter 2 (SLGT2) in obese insulin-
resistant mice blocks microglia activation in the hypothalamus
and restores insulin sensitivity (90, 91). Microglia are crucial in
the development of obesity and T2D as they initiate the
inflammatory response following overnutrition and increased
circulating free fatty acids (13).
Recently, mitochondrial dynamics in microglia have begun to
be studied, primarily in the hypothalamus. Three days of HFD in
mice led to an increase in activated DRP1 in hypothalamic
microglia, and mitochondria were decreased in size and
increased in number (15) (Figure 1). High-fat feeding also
increased expression of the mitochondrial protein UCP2
(Uncoupling protein 2) in microglia (15). UCP2 plays a critical
role in mitochondrial function, including control of ROS
generation (92, 93) and is highly expressed in activated
microglia (94). Selective deletion of Ucp2 in microglia of adult
mice (Ucp2MGKO) prevented changes to mitochondrial dynamics
induced by HFD (15); mitochondria did not change in size,
number or coverage. Ucp2MGKO mice did not present withNovember 2020 | Volume 11 | Article 580879
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levels were reduced. Furthermore, Ucp2MGKO mice were
protected from diet-induced obesity; their food intake was
reduced, energy expenditure increased, and insulin sensitivity
improved compared to control mice on HFD. It has been
previously reported that HFD alters POMC synaptic input
organization via reactive gliosis (89), Ucp2MGKO mice were
protected, and synapses onto POMC cell bodies were increased
along with increased POMC activation (15). This suggests that
activated microglia may be upstream controllers of synaptic
plasticity and astrogliosis in response to overfeeding and
present a potential therapeutic avenue for alleviating obesity.
As yet the effects of other mitochondrial proteins in the microglia
have not been studied nor has the role of microglia in the DVC in
DIO models.MITOCHONDRIAL DYNAMICS AND
GLUCOSE METABOLISM IN THE BRAIN
Glucose is the main fuel utilized by the brain where brain glucose
metabolism also provides the energy and precursors for the
biosynthesis of neurotransmitters (95); therefore, tight
regulation of glucose homeostasis is essential to maintain
blood glucose level for optimal brain and CNS function.
Glucose is a large polar molecule which cannot easily pass the
lipid cell membrane by simple diffusion; therefore, entry of
glucose into the CNS and its cells are achieved by transport
proteins known as glucose transporters (96, 97). Glucose
transporters are comprised of two main types which include
sodium-glucose linked transporters (SGLTs) which symport
glucose across the cell membrane with Na+ along a sodium
gradient, and sodium-independent transporters (GLUTs), which
transport glucose across the plasma membrane by a facilitated
diffusion mechanism (96, 97). GLUT-1 is expressed by
endothelial cells at the BBB and is the predominant transporter
which is responsible for the movement of glucose into the brain
(98), where it is then taken up by neurons and astrocytes which
predominantly express GLUT3 and GLUT1, respectively (99–
101). While nearly all of the six identified SGLTs, apart from
SGLT5, have been shown to be expressed in the brain; the
distribution of SGLT expression and their contribution to
glucose uptake differ strongly across the brain (102, 103).
SGLT1 is the most studied of this family, where reports have
shown that SGLT1 accounts for 80% of SGLT-mediated glucose
uptake in the midbrain (102) and that 45% of GE-neurons tested
in the ventromedial hypothalamus (VMH) are activated by an
SGLT1-specific ligand (104).
Following entry to the CNS, the MBH and DVC sense
glucose, circulating hormones including insulin, and nutrient
availability to control CNS glucose levels and glucose metabolism
by alterations in feeding behavior, HGP, and peripheral glucose
uptake and utilization (70, 105). For some time, the intracellular
mechanisms underlying the ability of these cells to sense,
respond to, and influence changes in glucose homeostasis haveFrontiers in Endocrinology | www.frontiersin.org 6been unclear. However, emerging research is beginning to show
that the dynamic nature of mitochondria, their energy sensing
properties, and their ability to undergo fusion and fission, may be
critical for the ability of these cells to contribute to the central
regulation of metabolism.GLUCOSE SENSING IN THE
HYPOTHALAMUS
The hypothalamus contains several nuclei which are involved in
the central control of metabolism, including the ARC,
ventromedial, paraventricular (PVN), and dorsomedial
hypothalamus (DMH) (106) (Figures 2A–C). Specialized
glucose sensing cells are present within hypothalamic nuclei
which integrate and control neuroendocrine signaling and
function and play an essential role in the regulation of
systemic glucose levels, acting as a critical site for counter-
regulatory mechanisms in response to both hypo- and
hyperglycemia (106–108).
Neurons in the ARC control systemic glucose levels by neural
regulation of HGP (108), whereas glucose sensing neurons in the
VMH prevent severe hypoglycemia by activating the counter-
regulatory response (CRR) which engages several defensive
mechanisms to restore glucose homeostasis. Glucose sensing
neurons detect changes in glucose levels either above or below
2.5 mM (109) and respond to extracellular glucose concentration
by changing their firing rate; glucose-excited (GE) cells increase
their rate of neuronal firing, whereas glucose-inhibited (GI) cells
decrease their firing when exposed to a rise in extracellular
glucose (107, 110). Neuronal glucose responsiveness is
associated with the activity of KATP channels which couple the
energy status of the cell and electrical activity, closing the channel
and triggering depolarization in a high ATP/ADP ratio and
opening the channel causing hyperpolarization in a low ATP/
ADP ratio (111, 112) (Figure 2Bii). In response to changing
energy demand and supply, mitochondria adapt by changing the
capacity and/or efficiency of ATP production which will
therefore influence the activity of KATP channels and neuronal
activation of glucose sensitive cells.
Glucose transporters, both GLUTs and SGLTs, have also been
implicated in hypothalamic glucose sensing. GLUT2 is required
for glucose sensing in pancreatic b-cells and evidence suggests that
it may also perform a similar role in the brain. For example,
GLUT2 ShRNA induced impaired GLUT2 function in the ARC,
blunted the increase in insulin secretion following administration
of a glucose bolus and diminished glucoprivic feeding behavior
(113, 114). Furthermore, transgenic mouse lines with either brain-
specific GLUT2 deletion (115) or inhibition of GLUT2-mediated
extracellular glucose detection (116, 117) also support the role of
GLUT2 in hypothalamic glucose sensing and control of food
intake. Another member of the GLUT family, GLUT4, has been
implicated in glucose sensing, particularly as it is expressed in 57%
of GE neurons and 63% of GI neurons in the VMH (118). Indeed,
it has been shown that the CRR to hypoglycemia is impaired inNovember 2020 | Volume 11 | Article 580879
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reduction in hypothalamic SGLT1 expression using ShRNA was
found to improve the CRR to hypoglycemia, leading to enhanced
HGP, showing that SGLT1 in the VMH is also involved in glucoseFrontiers in Endocrinology | www.frontiersin.org 7sensing and regulation of glucose homeostasis (120). It would
therefore seem that glucose transporters also contribute to the
glucose sensing machinery in the hypothalamus, and further work
is required to determine how glucose availability by glucoseFIGURE 2 | The MBH and DVC are involved in central glucose sensing and control of glucose metabolism: The MBH and DVC are distinct areas which are involved
in both glucose sensing and glucose metabolism (A). Glucose sensing cells in the MBH (B) are present in both the VMH (Bi) and ARC (Bii). In the VMH increased
glucose leads to mitochondrial fission and increased neuronal activity (Bii). In the ARC, glucose-inhibited (GI) AgRP and glucose-excited (GE) POMC neurons utilize
the Na+/K+-ATPase (NKA) or KATP channels in order to couple extracellular glucose levels and energy status with neuronal activity (Bii). Astrocytes also influence the
activity of POMC neurons in response to changes in glucose availability (Bii). The MBH also influences glucose metabolism (C), where neuronal activity and
increased mitochondrial fission and neuronal activity in VMH neurons induce glucose-stimulated insulin secretion (GSIS) from the pancreas and decrease glucose
production (Ci). Mitochondrial dynamics in AgRP and POMC neurons in the ARC influence neuronal activity of these neurons in response to fasted vs fed states
(Cii). Inhibition of mitochondrial fusion in POMC neurons inhibits GSIS (Cii). The DVC is also able to sense glucose (D), utilizing KATP channels to transduce
changes in extracellular glucose levels and therefore energy availability to neuronal activity (Di). Various cells have been implicated in glucose sensing in the DVC,
including catecholaminergic-, GABAergic-, POMC neurons, and astrocytes (Dii). The DVC also influences glucose metabolism (E) by insulin signaling mediated
ERK1/2 activation of KATP which decreases glucose production (Ei). Mitochondrial fission inhibits insulin receptor signaling in the DVC and impairs DVC control of
glucose homeostasis by inhibiting reduced HGP (Eii). Abbreviations: CRR, counter-regulatory response; GCK, glucokinase; GLUT, glucose transporter.November 2020 | Volume 11 | Article 580879
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ATP production by mitochondria may be linked in the act of
hypothalamic glucose sensing.
Astrocytes also play a crucial role in regulation of glucose
homeostasis, modulating glucose availability, and therefore the
levels of brain glucose metabolism, via control of glucose transport
across the BBB by GLUT-1, which is highly expressed in astrocytes
(16, 121). This is exemplified by the finding that IR-KO in GFAP+
astrocytes also resulted in reduced expression of GLUT1 and a
concomitant reduction in CSF glucose concentration (16). As well
as responding to insulin and leptin (16, 122), astrocytes also
express receptors for the hormone glucagon-like peptide 1
(GLP-1) (123–125). Activation of GLP-1 receptors in astrocytes
of the hypothalamus inhibited astrocytic glucose uptake and
promoted fatty acid utilization (126). Furthermore, knockout of
GLP-1 receptors from hypothalamic astrocytes abolished
alterations in mitochondrial dynamics associated with acute
glucose exposure ex vivo (126). In the ARC, ablation of
astrocytic GLP-1 receptors in mice improved glucose availability
and peripheral glucose metabolism (126), further highlighting the
role for astrocytes in control of glucose homeostasis.
AgRP and POMC neurons of the ARC have opposing effects
on glucose metabolism (127) (Figure 2Cii). The mechanisms
which allow these two cell types to respond to, and influence,
whole body energy status have been elusive. However,
mitochondrial dynamics in both AgRP/NPY and POMC
neurons have recently been shown to be regulated by
nutrition in an opposing manner in these two cell types (62,
64) (Figure 2Cii). Changes in mitochondrial dynamics are
involved in how these cells respond to glucose levels by
altering neuronal activation and thereby influence systemic
glucose metabolism.GLUCOSE SENSING AND POMC NEURONS
Neuronal activity of anorexigenic POMC is influenced by
extracellular glucose levels, where a subset of POMC neurons
are GE (64, 128, 129). In the postprandial state, when
extracellular glucose rises, KATP channels in POMC neurons
close, leading to depolarization and increased neuronal firing
(128, 129) (Figure 2Bii). GE POMC neurons exhibit a 2.26 +/−
0.23-fold faster firing rate in 5 mM glucose compared to 3 mM
glucose (129). Transgenic expression of a mutant Kir6.2 subunit
in POMC neurons, which prevents ATP-mediated closure of
KATP channels, resulted in a failure of POMC neurons to increase
their firing rate in response to high glucose levels and an
impairment in the whole-body response to systemic glucose
load (129). KATP channel function is therefore required for
activation of POMC neurons by glucose which contributes to
the overall control of glucose homeostasis. Furthermore,
although POMC neurons are clearly activated by glucose (129),
it has been argued that no study has yet shown that glucose
directly modulates the activity of these neurons (109). Instead, it
has been hypothesized that glucose modulates synaptic
remodeling to alter the frequency of excitatory postsynapticFrontiers in Endocrinology | www.frontiersin.org 8currents onto POMC neurons (130), perhaps by retraction of
glial coverage (131) (Figure 2Bii).
HFD decreases spontaneous activity and hyperpolarizes the
membrane potential of POMC neurons (68, 132). Glucose
responsiveness by POMC neurons is also abolished in obese
mice following a HFD, which is linked to an increase in the
mitochondrial protein UCP2. In pancreatic b-cells, UCP2
negatively controls glucose sensing by mediating proton leak
across the inner mitochondrial membrane, decreasing the yield
of ATP from glucose (133). In POMC neurons, UCP2 is also
involved in diet-induced loss of glucose sensing, perhaps by
decreasing ATP production by POMC neurons (129). Genetic
knockdown of Ucp2 can prevent diet induced obesity and restore
insulin sensitivity in leptin deficient ob/ob mice (129, 133). These
results highlight the importance ofmitochondria in glucose sensing
and illustrate that disruption of these processes following excessive
energy intake may be an important pathogenic component in
obesity associated loss of glucose and insulin sensitivity in T2D.
Astrocytes in the ARC also play a role in glucose metabolism
by influencing POMC neuronal activity (16) (Figure 2Bii).
Neurons make approximately 13% of the brains ATP from
glucose which is transported across the BBB; the remaining
87% is generated by glial cells (134). Therefore, together,
astrocytes and neurons form a metabolic unit that is able to
monitor circulating nutrients to alter food intake and
energy homeostasis.
Inducible postnatal deletion of insulin receptor specifically in
GFAP+ astrocytes (GFAP-IR-KO) caused a loss insulin signaling
activation of Akt in astrocytes with no effect on peripheral
insulin signaling. Astrocyte-specific loss of insulin receptors
decreased hypothalamic glucose sensing as GFAP-IR-KO
blunted the activation of POMC neurons to cause an increase
in systemic glucose levels (16). The mitochondria play a critical
role in neuronal responses to fluctuations in nutrient availability
by inducing alterations in the mitochondrial network of nutrient
sensing neurons, including changes in mitochondrial
morphology, mitochondrial density, and coverage, and the
number of contacts between mitochondria and the ER (135,
136). For example, POMC neurons in GFAP-IR-KOmice exhibit
decreased mitochondrial density and mitochondrial coverage in
response to elevated glucose levels. Furthermore, in response to
glucose administration, GFAP-IR-KO mice had higher numbers
of ER–mitochondrial contacts in POMC neurons compared to
WT mice (16). These results illustrate how insulin signaling in
astrocytes is required for appropriate POMC neuronal function
in response to cellular metabolic needs and show how astrocyte–
neuronal crosstalk in the ARC influences metabolic homeostasis.MITOCHONDRIAL DYNAMICS IN POMC
NEURONS ASSOCIATED WITH GLUCOSE
METABOLISM
The mitochondria also act as energy sensors in anorexigenic
POMC neurons in order to balance energy demand and nutrient
supply, where food deprivation results in a decrease inNovember 2020 | Volume 11 | Article 580879
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(Figure 2Cii). Conversely, mitochondria number is highest,
and mitochondrial length and branching are decreased in
POMC neurons in fed and diet-induced obese mice when
compared to fasted or leptin deficient ob/ob animals (64, 137)
(Figure 2Cii).
MFN1 has recently emerged as a nutrient sensor in POMC
neurons which influences whole-body glucose metabolism as it
plays a key role in the central control of insulin release. Structural
and functional alterations in mitochondria were found in POMC
neurons with selective deletion of Mfn1 (64). Furthermore,
POMC Mfn1 KO impaired central glucose sensing, perturbed
glucose-stimulated insulin secretion (GSIS), and altered glucose
metabolism (65) (Figure 2Cii), indicating the importance of
mitochondrial fusion in POMC-mediated glucose homeostasis.
During normal metabolism of oxygen by mitochondria, ROS
are formed as a natural by-product (138). Release of ROS from
POMC neurons is required for POMC neuronal activation in
response to rising glucose levels (139, 140). ROS activate POMC
neurons by modulation of membrane potential and neuronal
firing to promote satiety and increase energy expenditure, for
example ROS levels are significantly higher in POMC neurons
following HFD feeding (137). Mitochondrial morphology is also
associated with ROS production and energy status (141). MFN1
appears to be important for this process in POMC neurons,
as Mfn1-specific KO in these cells results in increased
mitochondrial respiration and ROS production in response to
high glucose (65). Furthermore, transient excessive ROS
production in POMC neurons leads to defective GSIS
in POMCMfn1KO mice as central administration of two
chemically distinct ROS scavengers normalized GSIS in these
animals (65). Loss of MFN1 in POMC neurons therefore impacts
mitochondrial flexibility and interferes with POMC neuronal
responses, hindering glucose sensing and sympathetic nervous
system driven peripheral responses which modulate glucose
metabolism such as insulin release.
The fusogenic protein MFN2 is also important for
mitochondria–ER tethering (67). HFD results in a downregulation
ofMfn2 expression, increased mitochondrial density, and decreased
mitochondria–ER contacts in POMC neurons (64), illustrating that
MFN2 is involved in metabolic alterations following diet-induced
obesity and so may be involved in the central regulation of
energy balance.
Whilst liver glucose output and expression of gluconeogenic
genes were normal in POMCMfn1 KO loss of Mfn2 resulted in
enhanced HGP. These changes were a result of alterations in
mitochondrial morphology, reduced numbers of mitochondria–
ER contacts, and increased ER stress in POMC neurons. ER
contact is needed for Ca2+ uptake in the mitochondria (67). Diet-
induced obesity has been shown to reduce mitochondrial Ca2+
accumulation capacity in POMC neurons, leading to greater
levels of free intracellular Ca2+ which contributes in part to a
reduction in POMC neuronal excitability by activation of
hyperpolarizing Ca2+-activated K+ channels (68). It could
therefore be hypothesized that reduced mitochondria–ER
contact in POMCMfn2KO mice also results in alterations inFrontiers in Endocrinology | www.frontiersin.org 9POMC neuronal activity by changes in the levels of intracellular
Ca2+; however, this remains to be determined.
These results show that like MFN1, MFN2 is also required for
POMC neuronal function and systemic energy balance as it is
critical for mitochondria–ER interaction (64). POMCMfn1KO
was found to alter GSIS by increasing POMC ROS levels, Mfn2
deletion also increased ROS production, illustrating that there
may also be some shared roles for MFN1 and MFN2 in POMC
neuron function. Deletion of the other fusogenic protein Opa1 in
POMC neurons failed to produce the same phenotypic features
of either Mfn1 or Mfn2 KO; these data therefore illustrate the
importance of Mfn-specific mitochondrial functions in
POMC neurons for the regulation of whole-body energy/
glucose homeostasis.
The importance of mitochondrial fusion in the control of
glucose sensing in POMC neurons is also clear when examining
the role of the fission protein DRP1. Inducible deletion
of Drp1 in mature POMC neurons improves their glucose
responsiveness, as measured by stronger POMC neuronal
inhibition in response to decreased extracellular glucose levels
(63). This was paired with a significant improvement in
peripheral glucose tolerance, an increase in food intake in
response to glucoprivation, and enhanced hepatic counter-
regulatory responses to hypoglycemia (63) (Figure 2Cii).
Glucose metabolism increases levels of POMC ROS and
activation of the nuclear receptor Peroxisome proliferator-
activated receptor gamma (PPARg) which increases neuronal
firing (137). This crucial process is also linked to Drp1-induced
mitochondrial fission, as following exposure to rising glucose
load, POMC neurons with Drp1 deletion showed increased levels
of ROS and PPARg protein levels alongside greater neuronal
activation compared to control (63). Increased ROS and PPARg
levels in animals with POMC Drp1 deletion resulted in greater
POMC neuronal activity in response to metabolic shifts by
altering KATP channel expression (63). These results show that
DRP1-mediated mitochondrial fission plays a negative role in
POMC neuronal responses to glucose load and further highlight
that mitochondrial dynamism is critical for the central regulation
of glucose metabolism.GLUCOSE SENSING IN AGRP NEURONS
Much like in anorexigenic POMC neurons of the ARC, glucose is
also an important regulator of AgRP/NPY neuronal activity. For
example, I.P or ICV injection of glucose in rats produces a 1.8 mM
rise in circulating glucose and a 30–60% reduction in NPY and
AgRP mRNA in the ARC at 30- and 60-min post injection. After
90 min circulating glucose levels decline, and the suppressive effect
of glucose administration is lost, while NPY and AgRP levels
increase by 50% (142). These results illustrate that AgRP/NPY
neurons are sensitive to changes in circulating glucose levels and
respondaccordingly tomodulateenergybalancebyaltering levelsof
AgRP and NPY which influence energy intake and expenditure
(143–145). Half of AgRP/NPY expressing neurons of the ARC are
inhibited by physiological brain glucose levels (146). In response toNovember 2020 | Volume 11 | Article 580879
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to increased c-fos expression, enhanced hypothalamic NPY release,
depolarizationandgreaterneuronalfiring,andaconcurrentdrive to
feedwhen there is an energy deficit (147–149). A recent study using
NPY-deficientmice found that NPY is necessary for the immediate
feedingbehaviorandacuteglucosehomeostasis functionswhichare
governed by AgRP/NPY neuron activation (150).
While the exact mechanism by which decreased glucose
induces depolarization in AgRP/NPY neurons is yet to be
determined, the Na+/K+-ATPase (NKA) pump has been
evidenced as one of the molecules which converts low glucose
levels to changes in neuronal excitability in glucose sensitive cells
(Figure 2Bii). Fasting glucose levels suppress the enzymatic
activity of NKA by decreasing ATP-hydrolyzing activity by
half and ATP substrate availability by a third (151). These
changes lead to depolarization of GI AgRP/NPY neurons via
an increase in the level of intracellular Na+, illustrating how
suppression of NKA by decreased ATP availability in negative
energy states is tightly linked to AgRP/NPY activation (152)
(Figure 2Bii). In contrast, changes in the activity of the energy
sensor AMP-activated protein kinase (AMPK) has been shown
to be required for hyperpolarization and therefore inactivity of
GI neurons following exposure to glucose (152, 153). AgRP/NPY
neurons also play a fundamental role in mediating the central
inhibitory effect of insulin on HGP (55, 154), thereby illustrating
the dual role AgRP/NPY neurons play in modulating whole body
energy balance by responding to both insulin and glucose.MITOCHONDRIAL DYNAMICS IN AGRP/
NPY NEURONS ASSOCIATED WITH
GLUCOSE METABOLISM
As in POMC neurons, mitochondria also act as energy sensors in
AgRP/NPY neurons; however, the electrical and mitochondrial
morphological responses of AgRP/NPY neurons to nutrition
oppose those of POMC neurons. By sensing changes in
extracellular glucose levels neuronal activity of AgRP/NPY
neurons is increased during periods of fasting or negative energy
balance (155, 156). There are also parallel changes in
mitochondrial morphology in these neurons; for example, in
fasted states mitochondria in AgRP/NPY are decreased in size,
and mitochondrial density is increased (62, 157) (Figure 2Cii).
These changes are indicative of increased levels of mitochondrial
fission and suggest that fission may be a requirement for the
activation of orexigenic AgRP/NPY in times of negative
energy balance. Indeed, expression of the key fission protein
Drp1 has been found in AgRP/NPY neurons (62). However, as
yet, no studies have examined the effect of Drp1 KO in AgRP/NPY
neurons upon glucose sensing and metabolism. It would therefore
be interesting to see whether impairment of Drp1-dependent
mitochondrial fission decreases glucose responsiveness and
prevents increased neuronal activity in response to negative
energy balance in AgRP/NPY neurons, particularly as Drp1
KO improved neuronal glucose responsiveness in POMC
neurons (63).Frontiers in Endocrinology | www.frontiersin.org 10Paradoxically, in HFD-fedmice AgRP neurons are highly active
(137) and exert a greater inhibitory tone upon anorexigenic POMC
neurons (158). AgRP/NPY neurons are normally GI; however,
when exposed to HFD, these neurons show an increase in electrical
activity in response to elevated levels of glucose (62). Mitochondria
in AgRP neurons following HFD feeding were found to be
significantly larger; however, mitochondrial density was
decreased, indicating that nutrient excess in HFD leads to
increased fusion in AgRP neurons (62). Deletion of Mfn1 or
Mfn2 in AgRP/NPY neurons prevents fusion and impairs
neuronal firing frequency in diet-induced obesity (62),
illustrating that the induction of mitochondrial fusion is required
for the paradoxical neuronal activation of AgRP/NPY neurons
following exposure to HFD (Figure 2Cii). Impaired neuronal
activity of Mfn-deficient AgRP/NPY neurons was a result of
altered intracellular ATP levels as cell-selective administration of
ATP restored AgRP/NPY neuronal activity (62). Mfn2-KO mice
fed HFD also had improved glucose tolerance, demonstrating the
importance of mitochondria in whole body metabolic responses to
positive energy balance. Such results therefore show how
mitochondrial fission and fusion in AgRP/NPY neurons are
dynamically regulated by nutritional and metabolic status and
contribute to whole-body energy metabolism.GLUCOSE SENSING IN THE
VENTROMEDIAL HYPOTHALAMUS
The VMH also contains glucose sensing neurons and is another
key area which is involved in the control of glucose homeostasis
(118, 159, 160) (Figure 2Bi). Much like in the ARC, recent work
has also illustrated that DRP1-mediated mitochondrial fission is
essential for glucose sensing in the VMH and is therefore involved
in how the VMH regulates systemic glucose metabolism (161–
163) (Figure 2Ci). However, unlike in POMC neurons, Drp1
positively regulates glucose responsiveness of VMH neurons
(161, 162).
Systemic administration of glucose decreased mitochondrial
size and increased mitochondrial density without affecting total
mitochondrial area in VMH neurons which is suggestive of
glucose-induced mitochondrial fission (162) (Figure 2Ci).
Indeed, the ratio of active phosphorylated DRP1 to non-
phosphorylated DRP1 was significantly greater in VMH neurons
following glucose infusion, confirming glucose-induced
mitochondrial fission in these cells (162) (Figure 2Ci). Increases
in extracellular glucose induce an increase in DRP1 translocation to
mitochondria in the VMH; inhibition of this process blocks
mitochondrial ROS production in response to glucose and
impairs hypothalamic glucose sensing induced insulin secretion.
Mitochondrial ROS production by DRP1-mediated mitochondrial
fission in the VMH is also required for the satiation effect of
intracarotid glucose infusion (161) (Figure 2Ci).
Impairment of hypothalamic glucose sensing and central GSIS
has been described in animals fed a hypercaloric high-fat high-
sugar (HFHS) diet for 3 weeks (163). HFHS-fed animals failed to
increase mitochondrial ROS levels in response to an increase inNovember 2020 | Volume 11 | Article 580879
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restored both ROS levels and hypothalamic glucose sensing
induced insulin secretion in HFHS-fed animals. These HFHS
diet-induced features were associated with a disruption in
translocation of DRP1 to mitochondria in the hypothalamus in
response to CNS hyperglycemia, further illustrating that DRP1-
mediated mitochondrial fission and ROS production are
important for regulating glucose metabolism by the VMH and
can be impaired by caloric excess (161, 163).
Activation of DRP1 in the VMH is dependent upon the
mitochondrial protein UCP2, as phosphorylation of DRP1 and
therefore glucose-mediated mitochondrial fission, was absent in
Ucp2 KO mice (162). UCP2 has also been shown to modulate
neuronal activity in part by controlling ROS production (164).
UCP2 negatively regulates mitochondrial ROS production,
where ROS levels in VMH neurons are involved in mediating
GSIS in response to systemic glucose load (137, 161, 162). VMH
neurons withUcp2 KO responded to glucose administration with
an increased level of ROS compared to control animals; selective
re-expression of UCP2 in the VMH restored ROS levels,
illustrating that UCP2 enables VMH neuronal activation in
response to rising glucose by buffering ROS. Ucp2 KO animals
were also glucose intolerant and exhibited reduced insulin
sensitivity; these changes were also restored by re-expression of
UCP2 in VMH neurons (162). Such results illustrate how UCP2
influences mitochondrial dynamics and neuronal activity in the
VMH which are crucial for the regulation of glucose metabolism.
In conclusion mitochondrial dynamism in hypothalamic
nuclei such as the ARC and the VMH is essential for the
control of glucose homeostasis and the maintenance of energy
balance (Figure 2C). Mitochondria are unique energy sensors,
where alterations in mitochondrial products such as ATP, UCP2,
or ROS influence the neuronal activity of glucose sensing cells in
the hypothalamus, which in turn influences energy balance.GLUCOSE SENSING AND
MITOCHONDRIAL DYNAMICS IN THE DVC
Although much of the work regarding the CNS control of
metabolism and energy balance has concentrated on the
hypothalamus, the DVC of the brainstem is the first site for
the sensing and integration of peripheral neurochemical and
humoral signals which communicate energy status to the brain
(70, 165). Much like in the hypothalamus, glucose responsive
cells are present in all three nuclei of the DVC (166); the DVC is
therefore able to regulate glucose homeostasis by the CRR and is
also able to influence HGP via DVC-hepatic vagal efferent neural
circuitry (71, 167) (Figures 2D, E). The NTS also contains
neurons that are activated by gastric distension; this acts as a
postprandial satiety signal which reaches the NTS via vagal
afferent fibers from the gut (168, 169).
The NTS is anatomically well situated to be influenced by
dynamic changes in plasma glucose concentrations due its
proximity to the AP, which is a circumventricular organ, and
the presence of fenestrated capillaries within the NTS (170). It
has long been known that the NTS contains cells which areFrontiers in Endocrinology | www.frontiersin.org 11gluco-responsive (166, 171). A subset of NTS neurons show
depolarizing or hyperpolarizing responses to an increase or
decrease in extracellular glucose concentration and are also
involved in the CRR to hypoglycemia (172–176). NTS neurons
respond to increased levels of glucose in a similar way to those in
the hypothalamus which are mechanistically similar to
pancreatic b-cells. These cells employ glucokinase (GCK) to
monitor changes in glucose availability and mediate cellular
utilization of glucose, GCK therefore links increased glucose to
changes in membrane potential which occur via glucokinase-
dependent modulation of KATP channels (172, 175, 177) (Figure
2Di). For example, KATP antagonists blunt the responsiveness of
these NTS neurons to increased glucose (175, 177). It has also
been shown that KATP channels of NTS neurons which respond
to reductions in extracellular glucose levels, i.e. GI NTS neurons,
are blocked by hyperglycemia and so blunt the neuronal
response to low glucose levels (172). Therefore, in response to
hyperglycemia, these GI NTS neurons lose the ability to respond
to fast reductions in glucose, where pathological prolonged
hyperglycemia such as in diabetes, may negatively impact the
energy sensing abilities of KATP channels in the NTS (172).
There have been several neuronal types which have been
identified as NTS glucose sensing neuronal candidates which
play a role in regulating glucose metabolism. These include
GLUT2+ GABAergic neurons which control vagal output and
glucagon secretion (174, 177, 178), catecholaminergic neurons
which mediate hypoglycemic hunger (179, 180), and NTS
POMC neurons which are involved in short-term changes in
feeding control (181, 182) (Figure 2Dii). Astrocytes in the NTS
have also been shown to sense glucose and contribute to whole
body energy balance by regulation of the hypoglycemia-induced
counter-regulatory response (12, 183, 184) (Figure 2Dii). While
much work has illustrated that mitochondria and mitochondrial
dynamics are essential for the hypothalamic control of glucose
homeostasis and that the NTS also influences energy balance by
glucose sensing, how mitochondria are involved in these
processes in the DVC is currently unknown.
The NTS is also able to sense insulin and responds to acute
insulin by lowering HGP and regulating food intake and body
weight via an insulin-ERK1/2 mediated signaling cascade which
activates KATP channels in the DVC (70, 71) (Figure 2Ei).
Activation of KATP channels is sufficient to induce a reduction
in HGP and highlight the energy sensing abilities of KATP in the
DVC which therefore influence whole body glucose metabolism
(70). HFD feeding, or adenoviral-mediated constitutive
activation of DRP1 (Drp1-S637A), results in a loss of the
glucoregulatory effect of DVC insulin infusion (70, 72), where
adenoviral-mediated molecular inhibition of DRP1-mediated
mitochondrial fission by expression of a dominant negative
form of DRP1 (Drp1-K38A) was found to restore the
glucoregulatory effect of DVC insulin (72) (Figure 2Eii). These
HFD-induced alterations in the mitochondria and insulin
sensitivity in the DVC therefore require increased DRP1-
dependent mitochondrial fission, where a HFD-fed phenotype
could be recapitulated by adenoviral expression of a
constitutively active form of DRP1, indicating that diet-
induced changes in mitochondrial dynamism negatively affectNovember 2020 | Volume 11 | Article 580879
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these results show that mitochondria in the DVC are essential for
changes in peripheral glucose metabolism in response to DVC
insulin sensing and illustrate how the DVC is a key area in the
control of glucose homeostasis.MITOCHONDRIAL DYNAMICS
ELSEWHERE IN THE BRAIN
While this review has focused on the role of mitochondrial
dynamics in the hypothalamus and DVC in metabolism, the
influence of mitochondria on CNS function throughout the brain
has been studied. Mitochondrial dynamics are involved in a
number of neurodegenerative conditions including Alzheimer’s
disease, Parkinson’s disease, Huntington’s disease, and
amyotrophic lateral sclerosis (ALS) [reviewed in (185–188)].
Indeed, obesity and diabetes are known to increase the risk of
dementia (189, 190). Brain mitochondrial dysfunction in obesity
and diabetes is associated with inflammation, ER stress, oxidative
stress, all of which can exacerbate neurodegeneration. Upregulation
of the fusion regulator OPA1 confers a protective effect in cerebellar
granular neurons following excitotoxic insult (191), while ablation
of DRP1 from forebrain neurons leads to hippocampal atrophy
(192). Furthermore, mitochondria are transferred to adjacent
neurons following focal cerebral ischemia, and inhibition of
transfer worsened neurological outcomes (193). This suggests that
the transfer of functional mitochondria from astrocytes to neurons
after stroke supports cell viability and recovery. Such a mechanism
may even occur in response to the chronic low-grade inflammation
in obesity and diabetes in an attempt to protect neurons and
therefore warrants further investigation.CONCLUSION AND FUTURE
PERSPECTIVES
While we have some understanding of how mitochondrial
dynamics in the brain are associated with food intake and
glucose sensing, there are still many more questions to be
answered. The cell types involved in the hypothalamus have
begun to be dissected, but as yet there is little data on the roles of
specific cells in the DVC, and indeed for both regions the role ofFrontiers in Endocrinology | www.frontiersin.org 12mitochondria in astrocytes and microglia needs to be further
explored. Mitofusins and OPA1 also need to be studied in the
DVC in relation to overnutrition, obesity, and T2D. This review
has focused on diet-induced obesity and T2D; the genetic
etiology of obesity remains unknown, but genome wide
association studies (GWAS) of T2D have identified variants
associated with T2D (194). Future studies may investigate the
role of specific variants and what effects these have on
mitochondria in cells of the brain as well as physiological
effects on whole body metabolism. Finally, while mitochondrial
dynamics are being studied in relation to obesity and T2D,
changes to mitochondrial bioenergetics in the brain in these
conditions remain unknown and warrant future investigation.
A fine balance of mitochondrial network dynamics is required
for healthy brain function, T2D and obesity are modifiable risk
factors that if ameliorated could reduce the risk of developing
neurodegenerative comorbidities, and targeting mitochondrial
dysfunction in the brain could be the link between these
disorders. It is clear that mitochondria are crucial in the
development and maintenance of obesity and T2D, playing a
role in the control of glucose homeostasis and whole-body
metabolism across cell types in the hypothalamus and DVC.AUTHOR CONTRIBUTIONS
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14. Garcıá-Cáceres C, Fuente-Martıń E, Argente J, Chowen JA. Emerging role of
glial cells in the control of body weight. Mol Metab (2012) 1:37–46.
doi: 10.1016/j.molmet.2012.07.001
15. Kim JD, Yoon A, Jin S, Correspondence SD, Yoon NA, Diano S. Microglial
UCP2 Mediates Inflammation and Obesity Induced by High-Fat Feeding
Cell Metabolism Article Microglial UCP2 Mediates Inflammation and
Obesity Induced by High-Fat Feeding. Cell Metab (2019) 30:952–62.
doi: 10.1016/j.cmet.2019.08.010
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